Rhythm Pharmaceuticals Inc. (RYTM)
NASDAQ · Healthcare
Rhythm Pharmaceuticals Inc. Shareholder Equity 2016–2025
Rhythm Pharmaceuticals Inc. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Rhythm Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 139.1M, a 540.02% increase year-over-year.
- Rhythm Pharmaceuticals Inc. shareholder equity for 2025 were 139.1M, a 540.02% increase from 2024.
- Rhythm Pharmaceuticals Inc. shareholder equity for 2024 were 21.7M, a 87.20% decrease from 2023.
- Rhythm Pharmaceuticals Inc. shareholder equity for 2023 were 169.8M, a 35.76% decrease from 2022.
- Rhythm Pharmaceuticals Inc. shareholder equity for 2022 were 264.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Rhythm Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $139 |
| 2024 | $22 |
| 2023 | $170 |
| 2022 | $264 |
| 2021 | $284 |
| 2020 | $167 |
| 2019 | $281 |
| 2018 | $246 |
| 2017 | $145 |
| 2016 | $-33 |
Rhythm Pharmaceuticals Inc. Shareholder Equity — FAQ
Rhythm Pharmaceuticals Inc. (RYTM) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RYTM's shareholder equity history?
The chart and table above show Rhythm Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.